Page last updated: 2024-10-21

n-methyl-3,4-methylenedioxyamphetamine and Hyperuricemia

n-methyl-3,4-methylenedioxyamphetamine has been researched along with Hyperuricemia in 1 studies

N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.

Hyperuricemia: Excessive URIC ACID or urate in blood as defined by its solubility in plasma at 37 degrees C; greater than 0.42mmol per liter (7.0mg/dL) in men or 0.36mmol per liter (6.0mg/dL) in women. This condition is caused by overproduction of uric acid or impaired renal clearance. Hyperuricemia can be acquired, drug-induced or genetically determined (LESCH-NYHAN SYNDROME). It is associated with HYPERTENSION and GOUT.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lin, PY1
Lin, CC1
Liu, HC1
Lee, MD1
Lee, HC1
Ho, CS1
Chiu, NC1
Peng, CC1
Huang, FY1
Tsai, JD1

Other Studies

1 other study available for n-methyl-3,4-methylenedioxyamphetamine and Hyperuricemia

ArticleYear
Rasburicase improves hyperuricemia in patients with acute kidney injury secondary to rhabdomyolysis caused by ecstasy intoxication and exertional heat stroke.
    Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 2011, Volume: 12, Issue:6

    Topics: Acute Kidney Injury; Adolescent; Child; Female; Gout Suppressants; Hallucinogens; Heat Stroke; Human

2011